{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:10:39Z","timestamp":1791083439708,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ygyno.2024.06.009","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T13:15:44Z","timestamp":1719407744000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Aseem Rai","family":"Bhatnagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Alkamachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Allo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"Hijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2024.06.009_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2024.06.009_bb0015","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2024.06.009_bb0020","doi-asserted-by":"crossref","unstructured":"Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol. Oncol. 2004;92(3):744-51. https:\/\/doi.org\/10.1016\/j.ygyno.2003.11.048. (Erratum in: Gynecol Oncol. 2004 Jul;94(1):241\u20132. PMID: 14984936).","DOI":"10.1016\/j.ygyno.2004.04.002"},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.009_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.009_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/ecc.12115","article-title":"The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer","volume":"23","author":"Loizzi","year":"2014","journal-title":"Eur. J. Cancer Care (Engl.)"},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.009_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2013.11.003","article-title":"Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma","volume":"88","author":"Elshaikh","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.009_bb0040","first-page":"1715","article-title":"Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer","volume":"29","author":"Gadducci","year":"2009","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.009_bb0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejso.2007.01.009","article-title":"Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study","volume":"33","author":"Gemer","year":"2007","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.009_bb0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ygyno.2016.01.002","article-title":"Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer","volume":"140","author":"Jorge","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.009_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2024.06.009_bb0060","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish gynecologic Cancer Group (SweGCG) study","volume":"58","author":"St\u00e5lberg","year":"2019","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.009_bb0065","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e84","article-title":"Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish gynecological Cancer Group Study","volume":"30","author":"\u00d8rtoft","year":"2019","journal-title":"J. Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.009_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PGP.0000000000000805","article-title":"Substantial Lymphovascular space invasion is an adverse prognostic factor in high-risk endometrial Cancer","volume":"41","author":"Peters","year":"2022","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.009_bb0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.brachy.2020.12.006","article-title":"Substanial lymphovascular space invasion predicts worse outcome in early-stage endometrioid endometrial cancer","volume":"20","author":"Barnes","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ygyno.2024.06.009_bb0080","doi-asserted-by":"crossref","unstructured":"Bosse T, Peters EE, Creutzberg CL, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Mens JW, et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials. Eur. J. Cancer 2015;51(13):1742\u201350. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.015. Epub 2015 Jun 3. PMID: 26049688.","DOI":"10.1016\/j.ejca.2015.05.015"},{"issue":"9213","key":"10.1016\/j.ygyno.2024.06.009_bb0085","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"9717","key":"10.1016\/j.ygyno.2024.06.009_bb0090","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"PORTEC study group. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ygyno.2024.06.009_bb0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/COC.0000000000001043","article-title":"Recurrence risk stratification for women with FIGO stage I uterine endometrioid carcinoma who underwent surgical lymph node evaluation","volume":"46","author":"Ghanem","year":"2023","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.009_bb0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2016.05.037","article-title":"Lymphovascular space invasion in uterine corpus cancer: what is its prognostic significance in the absence of lymph node metastases?","volume":"142","author":"Neal","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.009_bb0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2023.02.053","article-title":"Is substantial Lymphovascular space invasion prognostic in patients with pathologically lymph node-negative endometrial Cancer?","volume":"117","author":"Pifer","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.ygyno.2024.06.009_bb0110","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7","article-title":"The grading of lymphovascular space invasion in endometrial carcinoma","volume":"86","author":"Hachisuga","year":"1999","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2024.06.009_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.009_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2024.06.009_bb0125","doi-asserted-by":"crossref","unstructured":"Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42 (8), 1\u201328. doi: 10.18637\/jss.v042.i08.","DOI":"10.18637\/jss.v042.i08"},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.009_bb0130","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e11","article-title":"Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer","volume":"32","author":"Tortorella","year":"2021","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.009_bb0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"Endometrial Cancer Staging Subcommittmmee, FIGO Women\u2019s Cancer Committee. FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2024.06.009_bb0145","series-title":"WHO Classification of Tumours Editorial Board. Female Genital Tumours, WHO Classification of Tumours","volume":"vol. 4","year":"2020"},{"key":"10.1016\/j.ygyno.2024.06.009_bb0150","author":"National Comprehensive Cancer Network"},{"issue":"1","key":"10.1016\/j.ygyno.2024.06.009_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation therapy for endometrial Cancer: an American Society for Radiation Oncology clinical practice guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.009_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2020.11.018","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"154","author":"Concin","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"7447","key":"10.1016\/j.ygyno.2024.06.009_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.009_bb0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ygyno.2022.01.007","article-title":"Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment","volume":"164","author":"Leon-Castillo","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2024.06.009_bb0175","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2024.06.009_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/COC.0000000000000129","article-title":"Influence of comorbidity on the risk of death: a single institution study of 1132 women with early-stage uterine cancer","volume":"40","author":"Elshaikh","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"issue":"32","key":"10.1016\/j.ygyno.2024.06.009_bb0185","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","article-title":"Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2","volume":"27","author":"Walker","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2024.06.009_bb0190","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/cncr.22727","article-title":"Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients","volume":"109","author":"Chan","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.06.009_bb0195","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.06.009_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamasurg.2020.5060","article-title":"Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high grade endometrial cancer staging","volume":"156","author":"Cusimano","year":"2021","journal-title":"JAMA Surg."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582400324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582400324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:23:26Z","timestamp":1738704206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582400324X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"alternative-id":["S009082582400324X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}